Clinical Trial Update: A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

View source ↗

Summary

Pfizer is recruiting participants for a study of Cibinqo (abrocitinib) in adults with atopic dermatitis to learn more about the study medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Cibinqo (abrocitinib)

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Status: RECRUITING